36008391|t|Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells.
36008391|a|Ammonium tetrathiomolybdate (TTM) is a copper chelator in clinical trials for treatment of Wilson's disease, tumors and other diseases. In the current study, we innovatively discovered that TTM is a novel NRF2 activator and illustrated that autophagy contributed to TTM-induced NRF2 activation. We showed that TTM treatment promoted NRF2 nuclear translocation and upregulated transcription level of NRF2 target genes including HMOX1, GCLM, and SLC7A11 in vascular endothelial cells (HUVECs). Moreover, NRF2 deficiency directly hindered TTM-mediated antioxidative effects. Followingly, we revealed that overexpression of KEAP1, a negative regulator of NRF2, significantly repressed NRF2 activation induced by TTM. Further mutation analysis revealed that KEAP1 Cys151 is a major sensor responsible for TTM-initiated NRF2 signaling, suggesting that KEAP1 is involved in TTM-mediated NRF2 activation. Notably, we found that TTM can trigger autophagy as evidenced by accumulation of autophagosomes, elevation of LC3BI-II/I, increase of LC3 puncta and activation of AMPK/mTOR/ULK1 pathway. Autophagic flux assay indicated that TTM significantly enhanced autophagic flux in HUVECs. Inhibition of autophagy with knockout of autophagy key gene ATG5 resulted in suppression of TTM-induced NRF2 activation. TTM also induced phosphorylation of autophagy receptor SQSTM1 at Ser349, while SQSTM1-deficiency inhibited KEAP1 degradation and blocked NRF2 signaling pathway, suggesting that TTM-induced NRF2 activation is autophagy dependent. As the novel NRF2 activator, TTM protected against sodium arsenite (NaAsO2)-induced oxidative stress and cell death, while NRF2 deficiency weakened TTM antioxidative effects. Finally, we showed that autophagy-dependent NRF2 activation contributed to the protective effects of TTM against NaAsO2-induced oxidative injury, because of ATG5 or SQSTM1 knockout aggravated NaAsO2-induced elevation of HMOX1, cleaved PARP and gammaH2AX. Taken together, our findings highlight copper chelator TTM is a novel autophagy-dependent NRF2 activator and shed a new light on the cure for oxidative damage-related diseases.
36008391	0	27	Ammonium tetrathiomolybdate	Chemical	MESH:C020809
36008391	57	61	NRF2	Gene	18024
36008391	104	131	Ammonium tetrathiomolybdate	Chemical	MESH:C020809
36008391	133	136	TTM	Chemical	MESH:C020809
36008391	143	149	copper	Chemical	MESH:D003300
36008391	195	211	Wilson's disease	Disease	MESH:D006527
36008391	213	219	tumors	Disease	MESH:D009369
36008391	294	297	TTM	Chemical	MESH:C020809
36008391	309	313	NRF2	Gene	18024
36008391	370	373	TTM	Chemical	MESH:C020809
36008391	382	386	NRF2	Gene	18024
36008391	414	417	TTM	Chemical	MESH:C020809
36008391	437	441	NRF2	Gene	18024
36008391	503	507	NRF2	Gene	18024
36008391	531	536	HMOX1	Gene	15368
36008391	538	542	GCLM	Gene	14630
36008391	548	555	SLC7A11	Gene	26570
36008391	606	610	NRF2	Gene	18024
36008391	640	643	TTM	Chemical	MESH:C020809
36008391	724	729	KEAP1	Gene	50868
36008391	755	759	NRF2	Gene	18024
36008391	785	789	NRF2	Gene	18024
36008391	812	815	TTM	Chemical	MESH:C020809
36008391	857	862	KEAP1	Gene	50868
36008391	904	907	TTM	Chemical	MESH:C020809
36008391	918	922	NRF2	Gene	18024
36008391	950	955	KEAP1	Gene	50868
36008391	971	974	TTM	Chemical	MESH:C020809
36008391	984	988	NRF2	Gene	18024
36008391	1024	1027	TTM	Chemical	MESH:C020809
36008391	1135	1138	LC3	Gene	66734
36008391	1169	1173	mTOR	Gene	56717
36008391	1174	1178	ULK1	Gene	22241
36008391	1225	1228	TTM	Chemical	MESH:C020809
36008391	1339	1343	ATG5	Gene	11793
36008391	1371	1374	TTM	Chemical	MESH:C020809
36008391	1383	1387	NRF2	Gene	18024
36008391	1400	1403	TTM	Chemical	MESH:C020809
36008391	1455	1461	SQSTM1	Gene	18412
36008391	1479	1485	SQSTM1	Gene	18412
36008391	1507	1512	KEAP1	Gene	50868
36008391	1537	1541	NRF2	Gene	18024
36008391	1577	1580	TTM	Chemical	MESH:C020809
36008391	1589	1593	NRF2	Gene	18024
36008391	1642	1646	NRF2	Gene	18024
36008391	1658	1661	TTM	Chemical	MESH:C020809
36008391	1680	1695	sodium arsenite	Chemical	MESH:C017947
36008391	1697	1703	NaAsO2	Chemical	-
36008391	1752	1756	NRF2	Gene	18024
36008391	1777	1780	TTM	Chemical	MESH:C020809
36008391	1848	1852	NRF2	Gene	18024
36008391	1905	1908	TTM	Chemical	MESH:C020809
36008391	1917	1923	NaAsO2	Chemical	-
36008391	1961	1965	ATG5	Gene	11793
36008391	1969	1975	SQSTM1	Gene	18412
36008391	1996	2002	NaAsO2	Chemical	-
36008391	2024	2029	HMOX1	Gene	15368
36008391	2039	2043	PARP	Gene	11545
36008391	2048	2057	gammaH2AX	Gene	15270
36008391	2098	2104	copper	Chemical	MESH:D003300
36008391	2114	2117	TTM	Chemical	MESH:C020809
36008391	2149	2153	NRF2	Gene	18024
36008391	2201	2234	oxidative damage-related diseases	Disease	MESH:D004194
36008391	Positive_Correlation	MESH:C020809	26570
36008391	Association	15368	18024
36008391	Positive_Correlation	MESH:C020809	14630
36008391	Association	11793	15270
36008391	Positive_Correlation	MESH:C020809	18024
36008391	Association	11793	15368
36008391	Association	11545	11793
36008391	Negative_Correlation	MESH:C017947	MESH:C020809
36008391	Association	MESH:C020809	66734
36008391	Association	MESH:C020809	56717
36008391	Association	MESH:C020809	11793
36008391	Association	15270	18412
36008391	Negative_Correlation	18024	50868
36008391	Association	18024	18412
36008391	Association	11545	18412
36008391	Association	15368	18412
36008391	Association	MESH:C020809	22241
36008391	Association	18024	26570
36008391	Negative_Correlation	14630	18024
36008391	Association	MESH:C020809	50868
36008391	Negative_Correlation	MESH:C020809	MESH:D009369
36008391	Negative_Correlation	MESH:C020809	MESH:D006527
36008391	Association	MESH:C020809	18412
36008391	Positive_Correlation	MESH:C020809	15368
36008391	Association	18412	50868

